PUBLISHER: BCC Research | PRODUCT CODE: 1168913
PUBLISHER: BCC Research | PRODUCT CODE: 1168913
The global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a compound annual growth rate (CAGR) of 15.3% for the forecast period of 2022 to 2027.
Drug discovery and development segment of the global proteomics market is expected to grow from $14.0 billion in 2022 to $26.1 billion in 2027 at a CAGR of 13.2% for the forecast period of 2022 to 2027.
Diagnostics segment of the global proteomics market is expected to grow from $7.4 billion in 2022 to $17.4 billion in 2027 at a CAGR of 18.5% for the forecast period of 2022 to 2027.
The study's scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOACs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets-North America, Europe, Asia-Pacific, and Rest of the World (ROW)-are included.
The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth to 2027.
Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.
Key industry acquisitions and strategic alliances are given for the five-year period from 2021 through 2027.
This report examines the main patent trends within the industry and profiles proteomics companies.